journal article·2018-12-10

Near-Infrared/pH Dual-Sensitive Nanocarriers for Enhanced Intracellular Delivery of Doxorubicin

Kaikai Wen, Mengxue Zhou, Huiru Lu, Ying Bi, Lifo Ruan, Jun Chen, Yi Hu

Publisher page

Abstract

Herein, we designed near-infrared (NIR)/pH dual-sensitive nanocarriers and evaluated its application to intracellular drug delivery. The nanocarriers were prepared based on amphiphilic poly(β-amino ester) (PBAE) containing o-nitrobenzyl moieties in the backbones and upconversion nanoparticles (UCNPs). UCNPs can convert NIR to UV that subsequently removes PEG segments from PBAE copolymers, which could enhance the protonation of PBAE in endo/lysosomes and facilitate the escape of the nanoparticles from lysosomes. In addition, we found the colocalization of the nanoparticles with mitochondria inside the cells, presumably resulting from high hydrophobicity and positive charges of the nanoparticles. The results showed that the nanocarriers with the aid of NIR could enhance the intracellular delivery of DOX, as compared with free DOX and NIR-free control. Furthermore, PBAE@UCNPs-DOX with NIR potently inhibited tumor growth in mice. Therefore, the intelligent micellar nanoparticles might provide a simple yet effective nanoplatform to achieve mitochondrion-targeting drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), 19B Yuquan Road, Beijing 100049, China

University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences

References (33)

Show source-provided references
1. 10.1021/acsbiomaterials.7b0082710.1021/acsbiomaterials.7b00827 ↗
2. 10.1021/acsbiomaterials.7b0087810.1021/acsbiomaterials.7b00878 ↗
3. 10.1021/acsami.6b0259410.1021/acsami.6b02594 ↗
4. 10.1002/adma.20060158810.1002/adma.200601588 ↗
5. 10.1021/acsbiomaterials.6b0045910.1021/acsbiomaterials.6b00459 ↗
6. 10.1021/acsbiomaterials.7b0020410.1021/acsbiomaterials.7b00204 ↗
7. 10.1038/s41598-018-21084-810.1038/s41598-018-21084-8 ↗
8. 10.2174/156802661766617022412100810.2174/1568026617666170224121008 ↗
9. 10.1016/j.actbio.2015.01.02610.1016/j.actbio.2015.01.026 ↗
10. 10.1021/acsami.6b0390510.1021/acsami.6b03905 ↗
11. 10.1021/acsbiomaterials.7b0040510.1021/acsbiomaterials.7b00405 ↗
12. 10.1016/j.biomaterials.2014.03.00510.1016/j.biomaterials.2014.03.005 ↗
13. 10.1021/ja209793b10.1021/ja209793b ↗
14. 10.1021/acsbiomaterials.6b0081510.1021/acsbiomaterials.6b00815 ↗
15. 10.1039/C5BM00002E10.1039/C5BM00002E ↗
16. 10.1021/acsbiomaterials.6b0050310.1021/acsbiomaterials.6b00503 ↗
17. 10.1016/j.jconrel.2005.04.02210.1016/j.jconrel.2005.04.022 ↗
18. 10.1039/C6BM00878J10.1039/C6BM00878J ↗
19. 10.2174/09298670978880331210.2174/092986709788803312 ↗
20. 10.1158/1535-7163.MCT-16-004810.1158/1535-7163.MCT-16-0048 ↗
21. 10.1021/acs.molpharmaceut.6b0101610.1021/acs.molpharmaceut.6b01016 ↗
22. 10.1021/nl100004m10.1021/nl100004m ↗
23. 10.1016/j.biomaterials.2014.11.02210.1016/j.biomaterials.2014.11.022 ↗
24. 10.1016/j.biomaterials.2011.08.05310.1016/j.biomaterials.2011.08.053 ↗
25. 10.1021/acs.biomac.6b0104310.1021/acs.biomac.6b01043 ↗
26. 10.1016/j.ab.2005.01.00610.1016/j.ab.2005.01.006 ↗
27. 10.1021/acs.accounts.6b0038210.1021/acs.accounts.6b00382 ↗
28. 10.1126/science.aaq114410.1126/science.aaq1144 ↗
29. 10.1007/s11664-017-5514-910.1007/s11664-017-5514-9 ↗
30. 10.1039/C7NR00532F10.1039/C7NR00532F ↗
31. 10.1038/nrm.2017.6610.1038/nrm.2017.66 ↗
32. 10.1016/j.ejphar.2017.10.04310.1016/j.ejphar.2017.10.043 ↗
33. 10.1021/acsnano.8b0390010.1021/acsnano.8b03900 ↗